Pembrolizumab Plus Bevacizumab for Treatment of Brain Metastases in Metastatic Melanoma or Non-small Cell Lung Cancer (NSCLC)
Clinical trial NCT02681549 · COMPLETED
Trial details
- NCT number
- NCT02681549
- Sponsor
- Yale University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2024-09-11
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.